Our therapeutic focus spans a lifetime – from pediatric to geriatric – we focus on disorders where no approved therapies currently exist.
Parkinson’s Disease Psychosis (PDP)
PDP is a non-motor symptom impacting around half of people with Parkinson’s over the course of their disease. Patients with PDP may see or hear things that others don’t or believe things that are not true.
Alzheimer’s Disease Psychosis (ADP)
According to the Alzheimer’s Association, over six million people in the United States are living with Alzheimer’s disease. Studies suggest that approximately 30 percent of patients diagnosed with Alzheimer’s disease have psychosis, commonly consisting of hallucinations and delusions.
Negative Symptoms of Schizophrenia
Patients may experience negative symptoms of schizophrenia (NSS), which may include reduction or absence of behaviors related to motivation and interest or expression. NSS is one of the main predictors of decreased quality of life in patients with schizophrenia. In the U.S. there is no FDA-approved treatment.
Rett Syndrome is a rare genetic neurological and developmental disorder that leads to problems with movement, coordination and communication. Despite affecting 6,000 to 9,000 females in the U.S. there is no FDA-approved treatment.
Acute & Chronic Pain
Patients suffering from acute pain, such as post-operative pain, or chronic pain, such as osteoarthritis, may receive opioids for pain management. Opioids have significant risk of abuse or addiction and every day in the U.S. nearly 130 people overdose on opioids. There is significant patient need for non-opioid analgesics.